Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Synairgen reports positive Phase II asthma trial data
The study investigated SNG001 in patients representing mild-moderate through to severe asthmatics, who caught a cold, and was well tolerated. The difficult to treat asthma patient catergory were
The study investigated SNG001 in patients representing mild-moderate through to severe asthmatics, who caught a cold, and was well tolerated. The difficult to treat asthma patient catergory were
The trial met its objectives and FDA’s criteria for bioequivalence between RedHill’s once daily RHB-102, and GlaxoSmithKline’s Zofran. RHB-102 is designed to prevent nausea and vomiting over 24
Cisplatin is a chemotherapy drug used to treat various types of cancers, including sarcomas, carcinomas, lymphomas, and germ cell tumors. Cisplatin injection is available in 1mg/mL packages in
Under the collaboration, Metabolon will apply its platform to discover and validate targets, and identify novel pharmacodynamic biomarkers for translation into the clinic. Metabolon has developed a proprietary
The FDA approved BINOSTO to treat osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. Utilizing EffRx’s formulation technology, BINOSTO is the first and
Under the agreement, which is subject to satisfaction of certain closing conditions, CTI will make an upfront payment of $15m and issue $15m shares of unregistered preferred stock
SUGARDOWN, a non-systemic dietary supplement, is a complex carbohydrate-based chewable tablet to moderate post-meal blood glucose for those concerned about their blood glucose levels. Boston will manufacture and
Proteins produced by both treated and control algae were tested with an in vitro activity test assay and found that the treated algae showed hormonal activity. The use
The Moratuwa facility will produce 2.5 billion Panadol brand of paracetamol tablets, annually, according to the Ministry of Industry and Commerce, reports news360.lk. Industry and Commerce minister Rishard
The transaction is expected to close in the second quarter, subject to certain closing conditions including regulatory approvals, and is expected to be immediately accretive. The acquired assets’